Establishment of a new parameter of glycemic variability assessed by continuous glucose monitoring in type 1 diabetes.

Establishment of a new parameter of glycemic variability assessed by continuous glucose monitoring in type 1 diabetes. - Establishment of a new parameter of glycemic variability in type 1 diabetes.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018430

Enrollment

Registered

2015-07-31

Start date

2013-10-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes

Interventions

Insulin degludec administration period

12 weeks The dosage was adjusted by the attending physician Once daily

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Aged over 20 years. Eligible participants had a known history of type 1 diabetes for at least 6 months, and had been treated for at least 6 months with a basal-bolus insulin regimen

Exclusion criteria

Exclusion criteria: Severe chronic heart failure more than the 3 grade in the NYHA classification. Severely impaired hepatic or renal function. Severe infection, heavy use of alcohol, perioperative status, pregnant or breastfeeding women or other reasons leading to the physician in charge to judge that the patient was unsuitable for study

Design outcomes

Primary

Measure	Time frame
Glycemic variability assessed by continuous glucose monitoring	—

Secondary

Measure	Time frame
Glycemic control Iusulin dose Hypoglycemia	—

Countries

Japan

Contacts

Public ContactShingo Iwasaki

Graduate School of Medicine, Osaka University Department of Metabolic Medicine

i-shingo@endmet.med.osaka-u.ac.jp06-6879-3732

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026